Pharmacokinetics of the bicyclic peptide tachykinin NK2 receptor antagonist MEN 11420 in rats and guinea-pigs

被引：0
|
作者：
Lippi, A [1 ]
Criscuoli, M [1 ]
Santicioli, P [1 ]
Maggi, CA [1 ]
机构：
[1] Menarini Ric, Dept Pharmacol, Florence, Italy
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1998年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
339P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models
    Lecci, A
    Carini, F
    Tramontana, M
    D'Aranno, V
    Marinoni, E
    Crea, A
    Bueno, L
    Fioramonti, J
    Criscuoli, M
    Giuliani, S
    Maggi, CA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (01): : 247 - 254
  • [42] NK(1) AND NK(2) RECEPTORS MEDIATE TACHYKININ AND RESINIFERATOXIN-INDUCED BRONCHOSPASM IN GUINEA-PIGS
    FOULON, DM
    CHAMPION, E
    MASSON, P
    RODGER, IW
    JONES, TR
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04): : 915 - 921
  • [43] ROLE OF D-TRYPTOPHAN FOR AFFINITY OF MEN-10207 TACHYKININ ANTAGONIST AT NK2 RECEPTORS
    ROVERO, P
    ASTOLFI, M
    RENZETTI, AR
    PATACCHINI, R
    GIACHETTI, A
    MAGGI, CA
    PEPTIDES, 1991, 12 (05) : 1015 - 1018
  • [44] SCH 206272:: a potent, orally active tachykinin NK1, NK2, and NK3 receptor antagonist
    Anthes, JC
    Chapman, RW
    Richard, C
    Eckel, S
    Corboz, M
    Hey, JA
    Fernandez, X
    Greenfeder, S
    McLeod, R
    Sehring, S
    Rizzo, C
    Crawley, Y
    Shih, NY
    Piwinski, J
    Reichard, G
    Ting, P
    Carruthers, N
    Cuss, FM
    Billah, M
    Kreutner, W
    Egan, RW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 450 (02) : 191 - 202
  • [45] THE NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONIST SR-48968 INTERACTS WITH HUMAN, BUT NOT RAT, CLONED TACHYKININ NK3 RECEPTORS
    CHUNG, FZ
    WU, LH
    VARTANIAN, MA
    WATLING, KJ
    GUARD, S
    WOODRUFF, GN
    OXENDER, DL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (03) : 967 - 972
  • [46] In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist
    Robineau, P
    Lonchampt, M
    Kucharczyk, N
    Krause, JE
    Regoli, D
    Fauchere, JL
    Prost, JF
    Canet, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) : 677 - 684
  • [47] A tachykinin NK3 receptor antagonist, SR 142801 (Osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs
    Daoui, S
    Cui, YY
    Lagente, V
    Emonds-Alt, X
    Advenier, C
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 1997, 10 (5-6) : 261 - 270
  • [48] A TACHYKININ RECEPTOR ANTAGONIST INHIBITS AND AN INHIBITOR OF TACHYKININ METABOLISM POTENTIATES TOLUENE DIISOCYANATE-INDUCED AIRWAY HYPERRESPONSIVENESS IN GUINEA-PIGS
    SHEPPARD, D
    SCYPINSKI, L
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (03): : 547 - 551
  • [49] Design, synthesis, and SAR of tachykinin antagonists:: Modulation of balance in NK1/NK2 receptor antagonist activity
    Albert, JS
    Aharony, D
    Andisik, D
    Barthlow, H
    Bernstein, PR
    Bialecki, RA
    Dedinas, R
    Dembofsky, BT
    Hill, D
    Kirkland, K
    Koether, GM
    Kosmider, BJ
    Ohnmacht, C
    Palmer, W
    Potts, W
    Rumsey, W
    Shen, LH
    Shenvi, A
    Sherwood, S
    Warwick, PJ
    Russell, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) : 3972 - 3983
  • [50] Structure determination and by-product profile of the NK2 receptor antagonist nepadutant, a bicyclic glycopeptide
    Weisshoff, H
    Nagel, T
    Hänsicke, A
    Zschunke, A
    Mügge, C
    FEBS LETTERS, 2001, 491 (03) : 299 - 304
12345